ESMO19 - Overlevingsdata MONALEESA-3 laat significant betere mOS zien met ribociclib+fulvestrant versus placebo+fulvestant. In gesprek met Dennis Slamon.

Episode metadata supplied by the publisher feed · Published Oct 5, 2019

Embed this episode

Attribution link and audio player

Ready to play

0:00 6:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 6 minutes long.

When was this Oncologie.nu episode published?

This episode was published on October 5, 2019.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!